• About us
• Contact

Advertisement

Person › Details

Paul G. Higham (Valo Therapeutics (FI))

Higham, Paul G. (Valo Therapeutics 202008– CEO before Glycotope + Immatics + Ark Therapeutics + GlaxoWellcome)

 

	Organisation	Valo Therapeutics (FI)
	Group	Valo Therapeutics (Valo Tx) (Group)
	Former/major organisation	Immatics Biotechnologies GmbH
	Group	Immatics (Group)
	Product	GlycoExpress™ cellular expression system (GEX™ technology)
	Product 2	therapeutic vaccine

Record changed: 2021-05-18

Advertisement

More documents for Paul G. Higham

• [1] Valo Therapeutics Ltd.. (8/3/20). "Press Release: Valo Therapeutics Appoints Industry Veteran Paul G Higham as CEO". Oxford & Helsinki....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.